OICR‐9429, the epigenetic inhibitor of H3K4me3, ameliorated the secretory IL‐18, IL‐1β and TF, demonstrating the inhibitive function for inflammation and thrombosis in mice with APS and a prospective area of investigation for APS therapy. This evidence concerns the gene IL1B and autoimmune polyendocrinopathy.